发明名称 PHARMACEUTICAL FOR PROMOTING FUNCTIONAL REGENERATION OF DAMAGED TISSUE
摘要 PROBLEM TO BE SOLVED: To provide novel regenerative medical treatment inducing functional tissue regeneration by mobilizing a large amount of stem cells to damaged sites.SOLUTION: This invention is based on the following: (1) a large amount of bone marrow-derived cells are mobilized in transplanted skin; (2) the mobilized bone marrow-derived cells are differentiated into any of dermal fibroblasts, adipocytes, muscle cells, vascular endothelial cells and epidermal keratinocytes in a transplanted skin graft, and in the mobilized bone marrow-derived cells, bone marrow-derived mesenchymal stem cells are contained; (3) what mobilize the bone marrow-derived mesenchymal stem cells to the graft from the peripheral blood are HMGB1, HMGB2 and HMGB3 released from necrotic tissue of the transplanted skin; (4) purified HMGB1, HMGB2 and HMGB3 promote migration of mesenchymal stem cells isolated from the bone marrow and cultured; (5) active substances including HMGB1 can be simply purified from an extract of a large number of organs including skin, brain and heart; (6) active substances allowing bone marrow mesenchymal stem cells to migrate can be simply extracted from cultured cells; and (7) a heparin column-purified fraction of a skin extract mobilizes a large amount of bone marrow-derived cells during brain damage.
申请公布号 JP2013227330(A) 申请公布日期 2013.11.07
申请号 JP20130136055 申请日期 2013.06.28
申请人 GENOMIX CO LTD;OSAKA UNIV 发明人 TAMAI KATSUHITO;YAMAZAKI TAKAHIKO;KANEDA YASUSHI
分类号 A61K35/12;A61K35/28;A61L27/00;A61P17/00;A61P43/00;C07K14/46;C12N5/071;C12N5/077;C12N5/0775;C12N15/09 主分类号 A61K35/12
代理机构 代理人
主权项
地址